How much is the orthopedic bone cement market worth?

As of 2027 the market size of orthopedic bone cement is valued at USD 858.97 million.

How is the orthopedic bone cement industry projected to perform over the next decade?

Orthopedic Bone Cement Market size was estimated at USD 819 million in 2026 and is projected to grow at a 5.8% CAGR from 2027 to 2036, crossing USD 1.44 billion by 2036.

How is aging-related joint degeneration influencing demand in the orthopedic bone cement market?

Aging populations and osteoporosis are increasing joint replacement procedures where cemented fixation is preferred for weaker bone structures. This is driving consistent usage as surgeons prioritize reliable implant anchoring and predictable surgical outcomes.

Why is trauma incidence and infection prevention shaping product adoption in the orthopedic bone cement market?

Rising accident and sports injury cases are increasing fracture repair procedures requiring immediate stabilization. At the same time, adoption of antibiotic-loaded cement is growing as hospitals prioritize infection control in high-risk orthopedic surgeries.

Why does antibiotic loaded bone cement dominate the orthopedic bone cement market?

Antibiotic Loaded Bone Cement held a 59.22% share in 2026 because it combines fixation performance with infection management, making it a preferred choice for hospitals and surgeons in joint replacement procedures.

Which end-use segment is growing fastest in the orthopedic bone cement market?

Outpatient Facilities are the fastest-growing end-use segment as more orthopedic procedures move to efficient surgical settings that support faster patient throughput and improved operating cost management.

Why is North America the leading orthopedic bone cement market?

North America accounted for a 53.66% market share in 2026, driven by high joint replacement volumes, established surgical networks, and routine use of advanced bone cement formulations.

What is supporting orthopedic bone cement market growth in Asia Pacific?

Asia Pacific is projected to expand at a 6.33% CAGR due to rising orthopedic procedures, improving surgical infrastructure, expanding hospital capacity, and broader access to cemented orthopedic interventions.

What are the key competitors in the orthopedic bone cement landscape?

Prominent players in the orthopedic bone cement market include Zimmer Biomet Holdings, Inc. (United States), Stryker Corporation (United States), Johnson & Johnson (DePuy Synthes) (United States), Smith & Nephew plc (United Kingdom), Heraeus Medical GmbH (Germany), Medtronic plc (Ireland), DJO Global (Enovis Corporation) (United States), Arthrex, Inc. (United States), Tecres S.p.A. (Italy), Cardinal Health, Inc. (United States).